Skip to Main Content

Journal Articles with Photographs of Visible Diseases and Conditions in People with Skin of Various Colors

Stevens-Johnson Syndrome

Balasundaram, S., Ranganathan, K., Umadevi, K., Gunaseelan, R., Kumaraswamy, N., Solomon, S., Devaleenol B., & Ambrose, P. (2011). Oral lesions associated with nevirapine-related Stevens Johnson syndrome: A report of four cases. Journal of Oral and Maxillofacial Pathology, 15(1), 39-45. DOI 10.4103/0973-029X.80024

Chen, Y-E., Chen, C-B., Chung, W-H., Hsiao, Y-P., & Chu, C-Y. (2016). Anti-osteoporotic agents-induced cutaneous adverse drug reactions in asians. Clinical and Translational Allergy, 6(Suppl 3), P89.

Fernando, S. L., & Broadfoot, A. J. (2010). Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening. CMAJ Canadian Medical Association Journal, 182(5), 476-480. DOI: 10.1503/cmaj.090401

Kodliwadmath, A. (2017). Phenytoin-induced Stevens–Johnson syndrome with myocarditis: A rare case report. International Medical Case Reports Journal, 10, 229-231. DOI 10.2147/IMCRJ.S135643

Leclair, M. A., Maynard, B., & St-Pierre, C. (2009). Acute generalized exanthematous pustulosis with severe organ dysfunction. CMAJ Canadian Medical Association Journal, 181(6-7), 393-396. DOI 10.1503/cmaj.090137

Namayanja, G. K., Nankya, J. M., Byamugisha, J. K., Ssali, F. N., Kityo, C. M., Rwambuya, S. D., Mugerwa, R.D., Mmiro, F.A., Morrison, C. S., & Salata, R. A. (2005). Stevens-Johnson syndrome due to nevirapine. African Health Sciences, 5(4), 338-340. DOI: 10.5555/afhs.2005.5.4.338

Paik, S., Pal, A., Sen, S., Pramanick, N., & Tripathi, S. K. (2015). A suspected case of efavirenz-induced Stevens-Johnson syndrome. Drug Safety Case Reports, 2(1), 15. DOI 10.1007/s40800-015-0019-z

Rachana, P. R., Anuradha, H. V., & Mounika, R. (2015). Stevens Johnson syndrome-toxic epidermal necrolysis overlap secondary to interaction between methotrexate and etoricoxib: A case report. Journal of Clinical and Diagnostic Research, 9(7), FD01-FD03. DOI 10.7860/JCDR/2015/14221.6244

Wang, C-W., Su, S-C., Hung, S-L,, Ho, H-C., Yang, C-H., & Wen-Hung Chung, W-H. (2016). Efficacy of tumor necrosis factor—a antagonists in Stevens&-Johnson syndrome and toxic epidermal necrolysis: a randomized controlled trial and immunosuppressive effects evaluation. Clinical and Translational Allergy, 6(Suppl 3), P32.